BBC Stock Price, Chart, Stats & News
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a dividend-paying ETF with a current dividend yield of 1.30% as of Jul 22, 2026. It pays $0.6554 per share over the trailing twelve months and distributes annually.
BBC chart
BBC returns
| YTD | 32.18% |
| 1Y | 136.81% |
| 3Y | 28.70% |
| 5Y | 2.63% |
| 10Y | 10.98% |
| 1Y volatility | 26.04% |
| 3Y volatility | 35.58% |
| Sharpe ratio | 0.81 |
About
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Top 10 BBC holdings
| Holding | Ownership |
|---|---|
Health care 1.32% | |
Health care 1.19% | |
Health care 1.18% | |
Health care 1.15% | |
Health care 1.13% | |
Health care 1.08% | |
Health care 0.97% | |
Health care 0.97% | |
Health care 0.95% | |
Health care 0.95% |
Related lists
Similar securities
Based on sector and market capitalization
